Beyondspring (BYSI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
BeyondSpring Inc., a biopharmaceutical company, has successfully filed a registration statement with the SEC for the issuance of over 1.2 million ordinary shares, as detailed in a prospectus supplement dated June 12, 2024. This move, executed in accordance with a Securities Purchase Agreement, aims to strengthen the company’s financial position. Legal opinions confirm that the shares, once issued and paid for, will be fully legitimate and non-assessable under Cayman Islands law.
For further insights into BYSI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue